Keratitis Clinical Trial
Official title:
Quantifying Microbial Keratitis to Predict Outcomes
This is a multiple site observational study that will review patient features (clinical and morphologic) over a 90 day period during care of participants with microbial keratitis with presence of clinically significant ≥2mm stromal infiltrate compared with participants with other forms of keratitis.
The primary objective of this study is to determine associations between participant features (clinical and morphologic) and best corrected visual acuity at Day 90. Imaging, focused on slit lamp photography and supplemented by other imaging markers will be collected for review. A medical record review at one year following participants initial visit will record any corneal procedure and visual acuity testing that occurred during this window. Participants will complete demographic, clinical, and standardized health surveys. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00513734 -
A Comparison of Hydrogel Dressings and Ocular Lubricants in the Prevention on Corneal Damage in the Critically Ill
|
N/A | |
| Enrolling by invitation |
NCT03436576 -
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eye
|
Phase 3 | |
| Recruiting |
NCT06229379 -
The Effects of a Large Language Model on Clinical Questioning Skills
|
N/A | |
| Completed |
NCT01268306 -
Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
|
Phase 4 | |
| Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
| Recruiting |
NCT05432336 -
Complex Ocular Infection, Optimization of Microbiological Diagnosis
|
||
| Completed |
NCT04169061 -
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
|
Phase 4 | |
| Completed |
NCT03237936 -
Effect of IKERVIS® Eye Drops Once Daily on the Quality of Vision in Dry Eye Disease Patients With Severe Keratitis
|
Phase 4 | |
| Completed |
NCT00001734 -
Screening for NEI Clinical Studies
|
N/A | |
| Recruiting |
NCT05255016 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Refractory Corneal Ulcers
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05255107 -
Safety and Effectiveness of the PXL Platinum 330 System With Riboflavin Solution for Previously Untreated Corneal Ulcers
|
Phase 2/Phase 3 | |
| Terminated |
NCT05250583 -
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis
|
Phase 2 | |
| Recruiting |
NCT02865876 -
Effectiveness of Corneal Accelerated Crosslinking for Infectious Keratitis
|
Phase 3 | |
| Terminated |
NCT02116062 -
Robotic Surgery of the Ocular Surface
|
N/A | |
| Recruiting |
NCT00838422 -
Reliability of Pachymetry Measurement With FD-oCT, ORA, Confoscan 4 and Ultrasound
|
N/A | |
| Completed |
NCT00949468 -
Microbiological Keratitis in a Countryside City of Brazil
|
N/A | |
| Completed |
NCT03586505 -
Tolerance to Light for Patients Suffering From Keratitis
|
N/A | |
| Completed |
NCT02186431 -
Contact Lenses and Infiltrative Keratitis
|
N/A | |
| Completed |
NCT05538793 -
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
|
||
| Not yet recruiting |
NCT05689996 -
Ozone-based Eye Drops as Adjuvant Therapy in Microbial Keratitis
|
Phase 3 |